RayzeBio, Inc. Common Stock
RYZB
RYZB: RayzeBio inc is a company operating as vertically integrated radiopharmaceutical therapeutics company. The main objective of the company is defeating cancer with radiopharmaceutical medicines. It has a created a pipeline of multiple drug candidates, in therapeutic areas with significant market opportunities. They have a portfolio of potential RPT drug and development candidates that includes late-stage clinical programs, development programs and discovery programs.
moreShow RYZB Financials
Recent trades of RYZB by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RYZB's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Stabilized compositions of radionuclides and uses thereof Jul. 25, 2023
-
Patent Title: Stabilized compositions of radionuclides and uses thereof Jan. 03, 2023
-
Patent Title: Stabilized compositions of radionuclides and uses thereof Nov. 15, 2022
Federal grants, loans, and purchases
Followers on RYZB's company Twitter account
Number of mentions of RYZB in WallStreetBets Daily Discussion
Recent insights relating to RYZB
Recent picks made for RYZB stock on CNBC
ETFs with the largest estimated holdings in RYZB
Flights by private jets registered to RYZB